Imperva's (IMPV) Sale Process Said on Hold - Bloomberg

October 19, 2016 6:55 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Imperva's (NYSE: IMPV) sale process is on hold, as potential suitors wait to see if the company's growth can improve enough to justify a higher price, according to a report from Bloomberg late on Tuesday. The report said expectations in terms of deal value have been raised given recovery in sales projections since pre-announcing disappointing second-quarter results.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot M&A, Mergers and Acquisitions, Rumors

Add Your Comment